Deaths from cardiovascular
disease (CVD) have seen the biggest
drop in 15 years, according to
figures released by the Australian
Bureau of Statistics (ABS).
Around 20,046 people died of
CVD in 2012 compared with 28,299
in 1998 while the proportion of
deaths caused by heart disease has
fallen from 22.2% in 1998 to 13.6%
in 2012.
ABS data also showed a 40% drop
in heart attack death rates during
the past 15 years.
While cautioning that now is not
the time to become complacent in
efforts to stem the tide of the effects
of CVD, NHF national director of CV
health Dr Rob Grenfell said the next
task was to address the resulting
burden on the health system as
more people are living with heart
damage and disability.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Mar 14
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.